Explore

Trendline Trendline
MacroGenics Extends Cash Runway to 2028 Through Asset Monetization and Manufacturing Divestiture

MacroGenics Extends Cash Runway to 2028 Through Asset Monetization and Manufacturing Divestiture

MacroGenics Extends Cash Runway to 2028 Through Asset Monetization and Manufacturing Divestiture
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5 Million
Trendline Trendline
MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M
Trendline Trendline
Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million